UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SCHEDULE 14A INFORMATION
Proxy
Statement Pursuant to Section 14(a) of the Securities Exchange Act
of 1934
(Amendment No. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
|
[ ] |
Preliminary Proxy Statement |
|
[ ] |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
[X] |
Definitive Proxy Statement |
|
[ ] |
Definitive Additional Materials |
|
[ ] |
Soliciting Material under §240.14a-12 |
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
|
Payment of Filing Fee (Check the appropriate box): |
||
|
[X] |
No fee required. |
|
|
[ ] |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|
|
(1) |
Title of each class of securities to which transaction applies: |
|
|
|
||
|
(2) |
Aggregate number of securities to which transaction applies: |
|
|
|
||
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined): |
|
|
|
||
|
(4) |
Proposed maximum aggregate value of transaction: |
|
|
|
||
|
(5) |
Total fee paid: |
|
|
|
||
|
[ ] |
Fee paid previously with preliminary materials. |
|
|
[ ] |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|
|
(1) |
Amount Previously Paid: |
|
|
|
||
|
(2) |
Form, Schedule or Registration Statement No.: |
|
|
|
||
|
(3) |
Filing Party: |
|
|
|
||
|
(4) |
Date Filed: |
|
 |
11409
Valley View Road
Eden Prairie, MN 55344-3617 www.nve.com |
June 20,
2008
Fellow Shareholders:
We cordially invite you to attend our 2008 Annual Meeting of Shareholders. The
meeting will be held at the SpringHill Suites by Marriott, 11552 Leona
Road, Eden Prairie, Minnesota, 55344, on Thursday, August 7, 2008 at 3:30
p.m. Central Daylight Time.
The items of business are described in our Proxy Statement.
There is a map containing directions to the Annual Meeting in our Proxy Statement
if you plan to attend the meeting and vote in person. Alternatively, you may
call us at (952) 829-9217 during normal business hours for directions to the
Annual Meeting.
Thank-you for your support of NVE Corporation.
| Sincerely, | ||
 Curt A. Reynders |
||
| Chief Financial Officer and Secretary | ||
PROXY
STATEMENT
ANNUAL
MEETING OF SHAREHOLDERS, AUGUST 7, 2008
TABLE OF
CONTENTS
|
11409
Valley View Road
Eden Prairie, MN 55344-3617 www.nve.com |
PROXY STATEMENT
ANNUAL MEETING OF SHAREHOLDERS, AUGUST 7, 2008
This Proxy Statement is furnished to shareholders of NVE Corporation, a Minnesota corporation (“NVE” or the “Company”), in connection with the solicitation of proxies by our Board of Directors for use at our Annual Meeting of shareholders to be held on Thursday, August 7, 2008 at 3:30 p.m. Central Daylight Time at the SpringHill Suites by Marriott, 11552 Leona Road, Eden Prairie, Minnesota, 55344, and at any adjournment or postponements of the meeting (the “2008 Annual Meeting”), for the purposes set forth in the accompanying Notice of Annual Meeting of Shareholders. This Proxy Statement and the accompanying form of Proxy were first mailed and made accessible to our shareholders on or about June 20, 2008.Annual Meeting Admission
Proof of ownership (such as a recent brokerage statement or letter from your broker) and a form of photo identification are required for admission to the 2008 Annual Meeting.
“Householding” of Documents
We are sending only one annual report, proxy statement, and Notice of Internet Availability of Proxy Materials to eligible shareholders who share a single address unless we received instructions to the contrary from any shareholder at that address. This practice, known as “householding,” is designed to reduce our printing and postage costs. If registered shareholders residing at addresses with other registered shareholders wish to receive separate annual reports, proxy statements, or Notices of Internet Availability of Proxy Materials in the future, they may contact Curt A. Reynders, our Secretary, at telephone number (952) 829-9217, or by mail to the address at the top of this page. You can also request delivery of single copies of our documents if you are receiving multiple copies.
Other Matters and Proposals of Shareholders
Our Board is not aware that any matter other than those described in this Proxy Statement will be presented for action at the 2008 Annual Meeting. If, however, other matters do properly come before the 2008 Annual Meeting, the persons named in our vote form intend to vote the proxied shares in accordance with their best judgment on those matters. If any matters properly come before the shareholders at our 2008 Annual Meeting, but we did not receive notice of it prior to June 5, 2008, the persons named in our vote form for the 2008 Annual Meeting will have the discretion to vote the proxied shares on such matters in accordance with their best judgment.
Proposals of shareholders intended to be presented at our next annual meeting of shareholders must be received by our Secretary at our executive offices in Eden Prairie, Minnesota, no later than March 22, 2009 for inclusion in our proxy statement and proxy relating to that annual meeting. The proposal must be in accordance with the provisions of Rule 14a-8 promulgated by the Securities and Exchange Commission under the Securities Exchange Act of 1934. It is suggested the proposal be submitted by certified mail with return receipt requested. Upon receipt of any such proposal, we will determine whether or not to include such proposal in our proxy statement and proxy in accordance with regulations governing the solicitation of proxies. Shareholders who intend to present a proposal at our next annual meeting of shareholders without including such proposal in our proxy statement must provide us with notice of such proposal no later than June 5, 2009. NVE reserves the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these and other applicable requirements.
Only shareholders of record at the close of business
on June 13, 2008 are entitled to execute proxies or to vote at the 2008
Annual Meeting. As of that date there were outstanding 4,644,083 shares of our
common stock, $0.01 par value per share (“Common Stock”). Each holder
of Common Stock is entitled to one vote for each share of Common Stock held
with respect to the matters mentioned in this Proxy Statement and any other
matters that may properly come before the 2008 Annual Meeting. A majority of
the outstanding shares of Common Stock entitled to vote are required to constitute
a quorum at the 2008 Annual Meeting. The affirmative vote of a plurality of
the voting power of the Common Stock present, in person or by proxy, and entitled
to vote at the 2008 Annual Meeting, is required to approve Proposal 1.
The affirmative vote of a majority of the voting power is required to approve
Proposal 2. Proxies indicating abstention from a vote and broker non-votes
will be counted toward determining whether a quorum is present at the 2008 Annual
Meeting, but will not be counted toward determining if a majority of the Common
Stock present has voted affirmatively.
Solicitation and Revocability of Proxies
We will pay the costs and expenses of solicitation
of proxies. In addition to the use of the mails, proxies may be solicited by
our directors, officers, and regular employees personally or by telephone, but
these people will not be specifically compensated for those services.
Proxies are solicited on behalf of the Board of
Directors. Any shareholder giving a proxy in such form may revoke it either
by submitting a new vote form or by completing a ballot at the meeting at any
time before it is exercised. Such proxies, if received in time for voting and
not revoked, will be voted at the 2008 Annual Meeting in accordance with the
specification indicated thereon. If no specification is indicated on a proxy,
such proxy will be voted in favor of Proposals 1 and 2 described in
this proxy statement.
You may view this year’s proxy materials
at http://www.nve.com/AnnualReports.php.
If you are a shareholder through a broker or bank,
you may vote your shares by mail or electronically. If you are a shareholder
of record, you may vote your shares by mail only. If at the close of business
on June 13, 2008 your shares were registered directly in your name with
our transfer agent, Illinois Stock Transfer Company, then you are a shareholder
of record.
Voting by Mail
To vote by mail, mark your selections on the
vote form, date and sign your name exactly as it appears on your vote form,
and mail the vote form in the enclosed postage-paid envelope.
Electronic or Telephone Voting
If you are a shareholder through a broker
or bank, you may vote online or via telephone by following the instructions
in the Notice Regarding the Availability of Proxy Materials. Electronic and
telephone voting is available 24 hours a day until 11:59 p.m., Eastern Daylight
Time, on August 6, 2008. You may also revoke your proxy at any time before
the 2008 Annual Meeting.
Electronic Enrollment
If you are a shareholder through a broker
or bank, you can enroll to receive notice of future meetings via e-mail at www.investordelivery.com.
The table below shows the number of our shares of Common Stock beneficially owned as of June 13, 2008 by (i) each person or group known by us to beneficially own more than five percent of our outstanding Common Stock, (ii) each director and nominee for director, (iii) each named executive officer set forth in the summary compensation table, and (iv) all of the directors, director nominees, and executive officers as a group.
|
Name of Beneficial Owner |
|
Address |
|
Shares
of |
|
Percentage
of |
|
|
Trigran Investments, Inc. |
630 Dundee Rd., #230 Northbrook, IL 60062 |
463,658 |
(2) |
10.0 |
% |
||
|
Independence Investments LLC |
160 Federal Street Boston, MA 02110 |
304,100 |
(3) |
6.5 |
% |
||
|
Daniel A. Baker President and CEO; Director |
11409 Valley View Rd. Eden Prairie, MN 55344 |
208,837 |
(4) |
4.3 |
% |
||
|
Curt A. Reynders Chief Financial Officer |
11409 Valley View Rd. Eden Prairie, MN 55344 |
27,000 |
(5) |
|
* |
||
|
Terrence W. Glarner Director |
160 Montrose Place St. Paul, MN 55104 |
20,200 |
(6) |
|
* |
||
|
Patricia M. Hollister Director |
3455 Lyman Blvd. Chaska, MN 55318 |
12,000 |
(5) |
|
* |
||
|
Robert H. Irish Director |
c/o NVE Corporation 11409 Valley View Rd. Eden Prairie, MN 55344 |
8,000 |
(5) |
|
* |
||
|
James D. Hartman Director |
c/o NVE Corporation 11409 Valley View Rd. Eden Prairie, MN 55344 |
6,500 |
(7) |
|
* |
||
|
All
directors and executive
officers |
282,537 |
5.8 |
% |
||||
|
*Less than 1% |
|
|
(1) |
Includes
shares held directly or in joint tenancy, shares held in trust, by broker,
bank or nominee or other indirect means and over which the individual
or member of the group has sole voting or shared voting and/or investment
power. Unless otherwise noted, each individual or member of the group
has sole voting and investment power with respect to the shares shown
in the table above. |
|
(2) |
Based
on information contained in Schedule 13F filed with the SEC on May 14,
2008. According to Schedule 13G/A filed jointly by Trigran Investments,
Inc., Douglas Granat, Lawrence A. Oberman, and Steven G. Simon with the
SEC on February 6, 2008,Trigran Investments, Inc., Douglas Granat, Lawrence
A. Oberman, and Steven G. Simon have shared voting and dispositive power
for all shares. Furthermore, Douglas Granat, Lawrence A. Oberman, and
Steven G. Simon are the controlling shareholders and sole directors of
Trigran Investments, Inc. and thus may be considered beneficial owners
of shares beneficially owned by Trigran Investments, Inc. |
|
(3) |
Based on information contained in Schedule 13F filed with the SEC on May 7, 2008. According to Schedule 13G filed with the
SEC on January 24, 2008, accounts managed on a discretionary basis by Independence Investments LLC are known to have the
right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of such securities. |
|
(4) |
Includes
200,000 shares issuable upon the exercise of options that are currently
exercisable. |
|
(5) |
Consists
solely of shares issuable upon the exercise of options that are currently
exercisable. |
|
(6) |
Includes
14,000 shares issuable upon the exercise of options that are currently
exercisable. |
|
(7) |
Consists solely of shares issuable upon exercise of options that are exercisable within 60 days of the June 13, 2008 record date. |
Our Audit Committee reviews and approves our proxy statement and the information it contains.
Since April 1, 2007, there has not been any transaction, or is there any currently proposed transaction, in which we were or are to be a participant and in which any related person had or will have a direct or indirect material interest.
Review and Approval of Related Party Transactions
The audit committee is responsible for reviewing and approving (with the concurrence of a majority of the disinterested members of the Board of Directors) any related party and affiliated party transactions as provided in the Amended and Restated Audit Committee Charter adopted by the Board of Directors of NVE Corporation on May 15, 2008. In addition, Section 4350(h) of the rules of The Nasdaq Stock Market, LLC provide that all related party transactions must be reviewed for conflicts of interest by the audit committee. In accordance with policies adopted by the audit committee, the following transactions must be presented to the audit committee for its review and approval:
1. Any transaction in which the Company was or is to be a participant (within the meaning of Securities and Exchange Commission (SEC) Regulation S-K, Item 404(a)), and a related person (as defined in Regulation S-K, Item 404(a)) has or will have a direct or indirect material interest (within the meaning of Regulation S-K, Item 404(a)).
2. Any contract or other transaction between the Company and one or more directors of the Company, or between the Company and an organization in or of which one or more directors of the Company are directors, officers, or legal representatives or have a material financial interest within the meaning of Minnesota Statutes, Section 302A.255.
In addition to the Company's Board of Directors complying with the requirements of Minnesota Statutes, Section 302A.255 with respect to any proposed transaction with a potential director's conflict of interest, all proposed transactions covered by the policy must be approved in advance by a majority of the members of the audit committee. If a proposed transaction covered by the policy involves a member of the audit committee, such member may not participate in the audit committee’s deliberations concerning, or vote on, such proposed transaction. Prior to approving any proposed transaction covered by the policy, the following information concerning the proposed transaction will be fully disclosed to the audit committee:
1. The names of all parties and participants involved in the proposed transaction, including the relationship of all such parties and participants to the Company and any of its subsidiaries.
2. The basis on which the related person is deemed to be a related person within the meaning of Regulation S-K, Item 404(a), if applicable.
3. The material facts and terms of the proposed transaction.
4. The material facts as to the interest of the related person in the proposed transaction.
5. Any other information that the audit committee requests concerning the proposed transaction.
The audit committee may require that all or any part of such information be provided to it in writing.
The audit committee may approve only those transactions covered by the policy that a majority of the members of the audit committee in good faith determine to be (i) fair and reasonable to the Company, (ii) on terms no less favorable than could be obtained by the Company if the proposed transaction did not involve a director or the related person, as the case may be, and (iii) in the best interests of the Company.
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934, as amended, requires our directors and executive officers, and persons who own more than 10% of our Common Stock, to file with the SEC initial reports of ownership and reports of changes in ownership of Common Stock. Executive officers, directors and greater than 10% shareholders are required by SEC regulations to furnish us with copies of all Section 16(a) reports they file. To our knowledge, based solely on review of the copies of such reports furnished to us during, or with respect to, the fiscal year ended March 31, 2008, all reports were filed with the SEC on a timely basis.
PROPOSAL 1. ELECTION OF BOARD OF DIRECTORS
There are five nominees to the Board this year:
|
Nominee and Principal Occupation |
Age |
Director Since |
||
|
Terrence W. Glarner, President, West Concord Ventures, Inc. |
65 |
1999 |
||
|
Daniel A. Baker, President and CEO, NVE Corporation |
50 |
2001 |
||
|
James D. Hartman, retired Chairman and CEO, Enpath Medical, Inc. |
62 |
2006 |
||
|
Patricia M. Hollister, Chief Financial Officer, FSI International, Inc. |
48 |
2004 |
||
|
Robert H. Irish, retired |
69 |
1992 |
All directors are to be elected at the 2008 Annual Meeting to serve until the 2009 annual meeting of shareholders. All of the nominees for election as directors are presently directors of the Company, and have been nominated for election by the Board. Biographical information for the nominees is provided below:
Terrence W. Glarner has been a director since 1999 and Chairman of the Board since January 2001. Since 1993, Mr. Glarner has been President of West Concord Ventures, Inc., a venture capital company. Mr. Glarner has a B.A. in English from the University of St. Thomas, a J.D. from the University of Minnesota School of Law, and is a Chartered Financial Analyst. Mr. Glarner currently serves as a director of two other publicly-held companies, Aetrium Inc. and FSI International, Inc. He is also a director of privately-held Bremer Financial Corporation.
Daniel A. Baker has been a director and the President and Chief Executive Officer since January 2001. From 1993 until joining NVE he was President and CEO of Printware, Inc., now known as Printware LLC, which manufactures and markets high-speed imaging systems. Dr. Baker has 30 years of experience in high-tech industry, including executive positions with Minntech Corporation and Percom Data Corporation. Dr. Baker holds Ph.D. and M.S. degrees in engineering from the University of Minnesota, an M.B.A. from the University of Minnesota, and a B.S. in engineering from Case Western Reserve University.
James D. Hartman has been a director since August 2006. He was Chairman of the Board of Directors of Enpath Medical, Inc. until it was acquired in June 2007 by Greatbatch, Inc. From October 2003 until June 2007, Mr. Hartman held a variety of positions with Enpath, including Chief Executive Officer from February 1996 until his retirement from that position in January 2006. Mr. Hartman holds an accounting degree from the University of Wisconsin-Eau Claire and an M.B.A. from the University of St. Thomas.
Patricia M. Hollister has been a director since 2004. Since 1998 she has been the Chief Financial Officer of FSI International, Inc., a company that designs, manufactures, markets and supports equipment used in the fabrication of microelectronics. Prior to joining FSI in 1995, Ms. Hollister was employed by KPMG LLP, where she served for more than 12 years on various audit and consulting engagements, most recently as a Senior Manager. Ms. Hollister is a director of various FSI-owned foreign subsidiaries.
Robert H. Irish has been a director since 1992. Mr. Irish has been retired since 2003. He was an information technology consultant from 1999 to 2003. Prior to becoming a consultant, he held various sales and sales management positions at Compuware, Prodea Software, Centron DPL, and IBM. Mr. Irish attended Rensselaer Polytechnic Institute and received a B.S. in Physics from Syracuse University.
The Board has no reason to believe that any of the nominees will be unable to serve as a director. The individuals named as proxies intend to vote for the nominees listed in this proxy statement. If any nominee should be unable to serve as a director, the individuals named as proxies intend to vote for the election of such person or persons as the Board may, in its discretion, recommend. The affirmative vote of a plurality of the voting power of the shares of Common Stock present, in person or by proxy, and entitled to vote at the Annual Meeting is required to elect each director.
The Board unanimously recommends a vote FOR each of the director-nominees.
Corporate
Governance Guidelines
We
operate under written Corporate Governance Guidelines, which are available through
the “Investors” section of our Website (www.nve.com).
Board Composition, Independence, and Meeting Attendance
Our Board consists of five directors. The Board
met six times and acted by written consent on three occasions in fiscal 2008
(fiscal years referred to in this document end March 31). Each director attended
all of the meetings of the Board and of the committees on which they serve.
The Board has determined that each of our directors, except Dr. Baker,
are independent as defined under NASDAQ Marketplace Rule 4200(a)(15) and applicable
SEC rules. In making this determination, the Board has concluded that none of
these members has a relationship that, in the opinion of the Board, would interfere
with the exercise of independent judgment in carrying out the responsibilities
of a director.
Executive Sessions of Outside Directors
As a matter of policy, the independent directors
regularly meet without the CEO or other company management present.
Board Committees
The Board has three standing committees: the Audit,
Compensation, and Nominating/Corporate Governance committees. Each committee
is governed by a written charter, all of which are available through the “Investors”
section of our Website (www.nve.com).
Audit Committee
The Audit Committee currently consists
of three independent directors: Ms. Hollister, Mr. Glarner, and Mr. Hartman.
The Audit Committee met five times in fiscal 2008. Our Board has determined
that each of the members meet the criteria of “audit committee financial
experts” as that term is defined under Section 407 of the Sarbanes-Oxley
Act of 2002 and the rules promulgated by the SEC in furtherance of Section 407.
The primary responsibility of the Audit Committee is to oversee our financial
reporting process on behalf of the Board and our shareholders. The Report of
the Audit Committee, including a description of the functions of the committee,
is included in this Proxy Statement.
Compensation Committee
The Compensation Committee currently
consists of Mr. Glarner, Ms. Hollister, and Mr. Irish. The Compensation
Committee met twice in fiscal 2008. The Compensation Committee reviews and sets
compensation guidelines for executive officers and other senior management,
and the composition and levels of participation in incentive compensation and
fringe benefits for all employees. The Compensation Committee also oversees
administration of our 2000 Stock Option Plan, as amended.
Compensation Committee Interlocks and Insider Participation
Each member of the Compensation Committee
has been determined to be independent as defined by NASDAQ Marketplace Rule
4200(a)(15) and to have no relationship with the company that would interfere
with the exercise of independent judgment as a Committee member. Each Committee
member has also been determined to be “non-employee directors” as
defined by Rule 16b‑3 under the Securities Exchange Act of 1934 and
“outside directors” as defined by Section 162(m) of the Internal
Revenue Code. No member of the Compensation Committee is or has been an officer
of NVE. We have no compensation committee interlocks—that is, none of
our officers serves as a director or a compensation committee member of a company
that has an officer or former officer serving on our Board or Compensation Committee.
Nominating/Corporate Governance Committee
The Nominating/Corporate Governance Committee
currently consists of all of our independent directors: Mr. Glarner, Mr. Hartman,
Ms. Hollister, and Mr. Irish. The Nominating/Corporate Governance
Committee met five times in fiscal 2008. The Committee’s functions include
selection of candidates for our Board, select members of various committees,
and address corporate governance matters.
Our process for identifying and evaluating candidates
to be nominated to the Board starts with an evaluation of a candidate by the
Nominating/Corporate Governance Committee and CEO. Candidates can be forwarded
to the Nominating/Corporate Governance Committee by members of our Board or
our CEO. The committee recommends to the Board the slate of directors to serve
as management’s nominees for election by the shareholders at the Annual
Meeting. The Committee will also consider candidates recommended by shareholders.
To date we have not engaged any third party to assist in identifying or evaluating
potential nominees.
Director Qualifications
In evaluating candidates, the Board will require that candidates possess, at a minimum, a desire to serve on the Company’s Board, an ability to contribute to the effectiveness of the Board, an understanding of the function of the board of a public company and relevant industry knowledge and experience. In addition, while not required of any one candidate, the Board would consider favorably experience, education, training or other expertise in business or financial matters and prior experience serving on boards of public companies. Collectively, the composition of the Board must meet the listing requirements of the NASDAQ Stock Market, where our Common Stock is listed. In evaluating any candidate for director nominee, the Board will also evaluate the contribution of the proposed nominee toward compliance with the NASDAQ Stock Market listing standards.
Shareholder Nominees
Shareholder proposals for nominations to the Board should be submitted to the Nominating/Corporate Governance Committee at our offices, 11409 Valley View Road, Eden Prairie, Minnesota, 55344. To be considered by the Board for nomination at the next succeeding annual meeting, nominations must be delivered not less than 90 days nor more than 120 days prior to the first anniversary of the mailing of the notice of the preceding year’s annual meeting. Shareholders’ proposals must provide the following information for each nominee: (i) the name, age, business address, and residence address of the person; (ii) the principal occupation or employment of the person; (iii) the number of shares of our stock owned by the person; (iv) the written and acknowledged statement of the person that such person is willing to serve as a director; and (v) any other information relating to the person that would be required to be disclosed in a solicitation of proxies for election of directors pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended, if the candidate had been nominated by or on behalf of the Board. Candidates recommended by our shareholders will be considered under the same standards as candidates that are identified by the Nominating/Corporate Governance Committee. No shareholders submitted director nomination proposals in connection with this year’s meeting.
Shareholder Communications With the Board and Director Attendance at Annual Meetings
Shareholders and others who wish to communicate with our Board as a whole or any individual director, may write to them at our offices, 11409 Valley View Road, Eden Prairie, Minnesota, 55344. The Secretary will forward any such written communication to the Board, or if indicated, to a specified individual member of the Board, unless the written communication is (i) a personal or similar grievance, a shareholder proposal or related communication, an abusive or inappropriate communication or a communication not related to the responsibilities or duties of the Board, in which case the Secretary has the authority to discard the communication or to take appropriate legal action regarding the communication; or (ii) a request for information about the company, a stock-related matter or any other matter that does not appear to require direct attention by the Board or any individual director, in which case the Secretary will attempt to handle the inquiry or request directly. All such communications will be kept confidential to the extent possible. We do not have a formal policy regarding attendance by members of the Board at our annual meetings of shareholders, but we encourage our directors to attend. All of our directors attended our 2007 Annual Meeting.
Code of Ethics
We have adopted a Code of Business Conduct and Ethics that applies to all of our employees and directors, including our principal executive officer, principal financial officer, and principal accounting officer. A copy of our Code of Business Conduct and Ethics is available from the “Investors” section of our Website (www.nve.com). We intend to post on our Website any amendment to, or waiver from, a provision of our Code of Business Conduct and Ethics that applies to our principal executive officer, principal financial officer, controller, and other employees performing similar functions within four business days following the date of such amendment or waiver.
Executive Officers
of the Company
We currently have two executive officers, Daniel A.
Baker and Curt A. Reynders. Dr. Baker is our principal executive officer
and Mr. Reynders is our principal financial officer. They are our only named
executive officers (“NEOs”). Biographical information about Dr. Baker
can be found under “Proposal 1. Election of Board of Directors.” Mr. Reynders,
age 45, has been NVE’s Treasurer and Chief Financial Officer since January
2006. From 2001 until his promotion to CFO, Mr. Reynders was our controller.
Before joining NVE he served in various accounting, auditing, and accounting
management positions with public accounting and industry firms. Mr. Reynders
earned a B.S. in Accounting and Economics from Morningside College.
CEO Succession Planning
At least annually, the Board reviews a succession
plan addressing the policies and principles for selecting a successor to the
CEO, either in an emergency situation or in the ordinary course of business.
The succession plan includes an assessment of the experience, performance,
skills, and planned career paths for possible successors to the CEO.
COMPENSATION DISCUSSION AND ANALYSIS
Compensation
Philosophy and Objectives
Our overall philosophy is that compensation
levels should be adequate to retain highly-qualified personnel without being
unreasonable or excessive. In determining annual compensation for senior managers,
we consider the manager’s position, performance, productivity, recent compensation
history, experience, and education. We also take into account whether an employee
has options or accumulated wealth from options. We consider the full range of
pay components, including, but not limited to, the desired mix of equity, salary,
and performance-based compensation. Performance-based compensation should reward
the achievement of specific annual objectives with the ultimate goal of profitable
growth and improving shareholder value. Our significant compensation and practices
and trends are summarized below.
Performance-based compensation
Certain of our senior managers have the
opportunity to receive performance-based cash compensation. We believe performance-based
compensation is appropriate where specific annual goals can be established,
measured, and linked to profitable growth and our ultimate objective of improving
shareholder value. The Compensation Committee sets individual thresholds and
targets for each eligible manager at the start of the fiscal year. The Compensation
Committee has discretion to increase performance-based compensation if thresholds
and targets are not met. No such discretion was used for fiscal 2008. The Compensation
Committee also has discretion to award bonuses not tied to specific performance
thresholds and targets. The only such bonus in the past two fiscal years was
a bonus paid to our CEO in fiscal 2008.
Reduced use of stock options
We have reduced our use of stock options
to compensate our NEOs and other employees since our adoption of the provisions
of Financial Accounting Standards Board (FASB) Statement of Financial Accounting
Standards (SFAS) No. 123(R) on April 1, 2006. SFAS No. 123(R)
requires us to recognize expenses associated with the issuance of options. For
example, no stock options were granted to our NEOs in fiscal 2008 or 2007.
No special benefits or perquisites for senior managers
Our practice has been to extend fringe
benefits to all of our employees. Our goal is to provide a benefit package of
equal or higher aggregate value than offered by companies with which we compete
for employees. Such benefits include paid vacations, holidays, 401(k) retirement
plans, Health Savings Accounts, tuition reimbursement, health insurance, life
insurance, dental insurance, and long-term disability insurance. We believe
these benefits help us attract and retain employees throughout the company.
Our senior managers have not received any significant benefits other than those
offered to all employees.
Actions Affecting Fiscal 2008 Compensation
Named Executive Officers’ Salary
The Company provides the NEOs and other
employees with base salary to compensate them for services rendered during the
fiscal year. Salary levels are typically considered annually as part of the
company’s performance review process as well as upon a promotion or other
change in job responsibility. Dr. Baker had agreed to voluntarily decrease his
salary for several years in order to reduce expenses and in consideration of
equity and performance-based compensation. Dr. Baker’s base salary
was $114,000 per year effective April 1, 2006. His salary was increased
to $152,000 per year effective January 1, 2007, to $175,000 per year effective
April 1, 2007, and to $225,000 per year effective April 1, 2008 in
consideration of his performance and to bring his salary closer to competitive
levels. Mr. Reynders’ salary was increased to $95,000 per year effective
with his promotion to CFO on January 16, 2006, to $105,000 per year effective
April 1, 2007, and to $125,000 per year effective April 1, 2008 in
consideration of his performance, which was evaluated as outstanding. The Compensation
Committee believes the salaries paid both Dr. Baker and Mr. Reynders
are lower than comparable positions at public companies with comparable revenues
or market capitalization, and that reliance on equity and performance-based
compensation provides motivation to facilitate profitable growth and to ultimately
increase shareholder value.
CEO Performance-Based Compensation and Bonus
Dr. Baker’s performance-based
incentive compensation in fiscal 2008 and recent years has been tied to weighted
percentages of revenue growth, weighted differently for different product lines,
on contract revenue, and on a percentage of revenue and profitability improvements
in certain product lines. Each component of performance-based incentive compensation
has a threshold of the prior fiscal year performance, meaning each performance
component requires improvement from the prior year. The Compensation Committee
sets performance criteria at the beginning of the fiscal year. The Committee
does not set compensation targets, but believes that the performance criteria
set a high standard, and that it would be difficult to achieve performance that
would result in CEO compensation comparable to public companies with comparable
revenues or market capitalization. Dr. Baker’s performance-based compensation
was based on predetermined criteria and most resulted from our revenue and income
growth in fiscal 2008 compared to fiscal 2007. In addition to performance-based
compensation, Dr. Baker was awarded a bonus in fiscal 2008 at the discretion
of the Compensation Committee, due to the Committee’s overall assessment
of Dr. Baker’s performance, which was evaluated as outstanding.
CFO Performance-Based Compensation
Mr. Reynders performance-based compensation for fiscal 2008 was based on a percentage of pretax income growth in fiscal 2008 compared to fiscal 2007. Criteria were set at the beginning of the fiscal year by the Compensation Committee. The Committee believes that Mr. Reynders’ performance criteria set a high standard of performance, and that it would be difficult to achieve performance that would result in CFO compensation comparable to public companies with comparable revenues or market capitalization.
Perquisites and Other Personal Benefits
We do not provide our NEOs or other senior managers with perquisites or personal benefits other than those available to all of our employees, because we do not currently believe such benefits are an appropriate use of company funds. We have not entered into change of control severance agreements with the NEOs or any other employees.
The Role of Named Executive Officers in Compensation Decisions
The Compensation Committee makes all compensation decisions for the CEO and his staff, including the CFO. The Compensation Committee is also responsible for any equity awards to any employee. The CEO annually reviews the performance of each member of his staff. The conclusions reached and recommendations based on these reviews, including salary adjustments and performance-based compensation, are presented to the Compensation Committee. The Compensation Committee has discretion to change any of the CEO’s recommendations.
Compensation Tax and Accounting Implications
Accounting for Stock-Based Compensation
Effective April 1, 2006 we adopted the provisions of, and began accounting for, stock-based compensation in accordance with, SFAS No. 123 (revised 2004), Share-Based Payment. Under the fair value recognition provisions of SFAS No. 123(R), we measure stock-based compensation cost at the grant date based on the fair value of the award and recognize the compensation expense over the requisite service period, which is generally the vesting period. We use the Black-Scholes standard option pricing model to determine the fair value of stock options for financial reporting and for the purposes of disclosures in this proxy statement.
Tax Implications of Incentive Stock Option Compensation
Options we award to employees are generally incentive stock options as defined under federal income tax laws. For alternative minimum tax purposes incentive stock option are treated as non-statutory stock options. Employees realize no taxable income and we are not entitled to a deduction at the time an incentive stock option is granted. If certain statutory employment and holding period conditions are satisfied before the employee disposes of shares acquired from the exercise of such an option, no taxable income results from the exercise and we are not entitled to any deduction. If the statutory holding periods are met, any gain or loss realized by the employee is treated as a capital gain or loss and we are not entitled to a deduction.
Except in the event of death, if shares acquired by an employee upon the exercise of an incentive stock option are disposed of by the employee before the expiration of the statutory holding periods (a “disqualifying disposition”), the employee is considered to have realized as compensation, taxable as ordinary income in the year of disposition, an amount, not exceeding the gain realized on such disposition, equal to the difference between the exercise price and the fair market value of the shares on the date of exercise. We are entitled to a deduction at the same time and for the same amount as the employee’s deemed realized ordinary income. Any gain or loss in excess of the amount treated as compensation is treated as a capital gain or loss. If the employee pays the option price with shares that were originally acquired pursuant to the exercise of an incentive stock option and the statutory holding periods for such shares are not met, the payment shares are considered a disqualifying disposition.
Tax Implications of Non-statutory Stock Option Compensation
Options awarded to non-employee directors are generally non-statutory stock options. The director realizes no taxable income, and we are not entitled to a deduction at the time a non-statutory stock option is granted. At the time shares are transferred to the director on exercise of a non-statutory stock option, the director realizes ordinary income, and we are entitled to a deduction equal to the excess of the fair market value of the stock on the date of exercise over the option price. On disposition of the shares, any additional gain or loss realized by the director is taxed as a capital gain or loss.
We have reviewed and discussed the Compensation
Discussion and Analysis required by Item 402(b) of Regulation S‑K
with management and, based on such review and discussions, we recommended
to the Board that the Compensation Discussion and Analysis be included in
this proxy statement.
COMPENSATION COMMITTEE MEMBERS
| Patricia
M. Hollister |
Terrence
W. Glarner |
Robert H. Irish |
|
Name and Principal Position |
|
Fiscal |
|
Salary ($) |
|
Bonus |
|
Stock |
|
Option |
|
Non- |
|
Change in |
|
All Other |
|
Total ($) |
|
Daniel A. Baker, President and CEO |
2008 |
175,000 |
22,762 |
- |
- |
79,012 |
- |
* |
276,774 |
|||||||||
|
|
2007 |
122,038 |
- |
- |
- |
79,371 |
- |
* |
201,409 |
|||||||||
|
Curt A. Reynders, Chief Financial Officer |
2008 |
105,000 |
- |
- |
- |
30,544 |
- |
* |
135,544 |
|||||||||
|
|
2007 |
95,000 |
- |
- |
- |
17,686 |
- |
* |
112,686 |
|||||||||
(1) The amounts in this column were paid based on performance achieved
during the fiscal year under plans approved by our Compensation Committee
at the beginning of the fiscal years and described in “Compensation Discussion
and Analysis.”
*All other compensation totaled less than $10,000 for each NEO, including
matching contributions made to 401(k) savings plans and Health Savings Accounts
on behalf of the NEOs, and life insurance premiums paid on behalf of the NEOs.
The NEOs participate in these benefit programs under the same terms as other
employees.
Grants
of Plan-Based Awards
There were no non-stock grants of incentive
plan awards, stock-based incentive plan awards, or awards of options, restricted
stock or similar instruments to either of our NEOs, Dr. Baker and Mr. Reynders,
in the past fiscal year.
Outstanding
Equity Awards at Fiscal Year-End
The following table sets forth outstanding
equity awards to our NEOs as of March 31, 2008:
|
|
|
Option Awards |
|
Stock Awards |
|
||||||||||||||
|
Name |
|
Number of |
|
Number of |
|
Equity |
|
Option |
|
Option |
|
Number |
|
Market |
|
Equity |
|
Equity |
|
|
Daniel A. Baker |
|
70,000 |
|
- |
|
- |
|
6.58 |
|
1/29/2011 |
|
- |
|
- |
|
- |
|
- |
|
|
|
|
35,000 |
|
- |
|
- |
|
29.65 |
|
5/7/2014 |
|
- |
|
- |
|
- |
|
- |
|
|
|
|
70,000 |
|
- |
|
- |
|
16.93 |
|
3/28/2015 |
|
- |
|
- |
|
- |
|
- |
|
|
|
|
25,000 |
|
- |
|
- |
|
14.76 |
|
8/24/2015 |
|
- |
|
- |
|
- |
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Curt A. Reynders |
|
2,000 |
|
- |
|
- |
|
6.09 |
|
7/26/2011 |
|
- |
|
- |
|
- |
|
- |
|
|
|
|
25,000 |
|
- |
|
- |
|
16.33 |
|
1/16/2016 |
|
- |
|
- |
|
- |
|
- |
|
Option Exercises and Stock Vested
There were no option exercises by our NEOs, and no additional vesting of their options during the most recent fiscal year.
Employment Agreements
We have an employment agreement with Dr. Baker that set his initial salary and contains non-competition, confidentiality, and assignment of invention provisions benefiting the Company. The agreement may be terminated by either Dr. Baker or us upon thirty days written notice. In addition, we may terminate Dr. Baker’s employment for cause or upon his death or incapacity. We have agreement with Mr. Reynders relating to non-competition, confidentiality and assignment of invention provisions benefiting the Company.
Post-Employment Compensation
Our NEOs receive no pension benefits, nonqualified deferred compensation, or other post-employment potential payments. Dr. Baker and Mr. Reynders are eligible to participate in the Company’s 401(k) retirement plan under the same terms as other employees.
Setting Named Executive Officers’ Compensation
We have no pre-established policy or target for the allocation between salary and performance-based compensation. The Compensation Committee does not use a comparison with a specific compensation peer group because we do not believe there are public companies of comparable size devoted substantially to all of the same markets in which we compete. The Compensation Committee has full and sole authority to retain and terminate compensation consultants to assist in the evaluation of CEO, executive staff, and director compensation. We have not employed consultants because we do not believe it is a necessary use of company resources, and we believe members of our Compensation Committee, by virtue of experience in compensation management and service on other boards, have reasonable knowledge of compensations practices. We review data on overall compensation trends such as salary and wage data from the U.S. Bureau of Labor Statistics, and we review the practices of various technology companies in the Twin Cities area.
Fiscal 2008 Named Executive Officer Compensation
For the fiscal year ended March 31, 2008, the principal components of compensation for NEOs were salary and performance-based compensation.
The following table summarizes non-employee director compensation in the fiscal year ended March 31, 2008:
|
Name |
|
Fees |
|
Stock |
|
Option |
|
Non- |
|
Change
in |
|
All
Other |
|
Total ($) |
|
Terrence W. Glarner |
- |
- |
36,380 |
- |
- |
- |
36,380 |
|||||||
|
James D. Hartman |
- |
- |
58,772 |
- |
- |
- |
58,772 |
|||||||
|
Patricia M. Hollister |
- |
- |
36,380 |
- |
- |
- |
36,380 |
|||||||
|
Robert H. Irish |
- |
- |
36,380 |
- |
- |
- |
36,380 |
Beginning
after their reelection to the Board at the 2008 Annual Meeting of Shareholders,
our non-employee directors will receive cash compensation of $2,000 per quarter,
plus an additional $200 per quarter for the Chairman of the Board of Directors
and an additional $125 per quarter for the Audit Committee Chair. On each reelection
to the Board beginning with the 2008 Annual Meeting of Shareholders, each non-employee
directors will be granted an immediately-vested nonqualified option to purchase
1,000 shares on each reelection to the Board. In addition to the cash compensation,
upon initial election non-employee directors automatically receive a nonqualified
option to purchase 6,000 shares of Common Stock vesting in 25% installments
beginning with the date of the grant and each year thereafter.
Previously our non-employee directors received
an immediately-vested option to purchase 2,000 shares on each reelection to
the Board but no cash compensation. On April 1, 2006 we adopted SFAS 123(R),
which requires the measurement and recognition based on estimated fair values
of compensation expense related to the options awarded to our directors. We
believe the reduction of annual option grants in favor of cash compensation
may reduce the total director compensation expense we recognize in the future.
Furthermore, we believe the addition of cash compensation
will help us attract and retain well-qualified directors, and we believe the
option component of director compensation helps align our directors’ interest
with our ultimate objective of improving shareholder value.
Fees Billed to Us by Ernst & Young During Fiscal 2008 and 2007
Audit FeesWe incurred total fees of $111,500 relating to the audit of the March 31, 2008 financial statements, review of the financial statements included in fiscal 2008 quarterly reports on Form 10‑Q, and other matters directly relating to the fiscal 2008 audit. Fees were $115,000 for similar services for the year ended March 31, 2007. Fees were higher in fiscal 2007 than in fiscal 2008 primarily due to expenses related to our first controls-based audit pursuant to Section 404 of the Sarbanes-Oxley Act.
Tax, Audit-Related, and All Other Fees
No fees were billed to us by Ernst & Young LLP, our independent registered public accounting firm, relating to tax compliance, audit-related services, or other services, except for $2,500 for tax-compliance matters in fiscal 2007.
Auditor Independence
The Audit Committee determined that the provision of tax-compliance services described above was compatible with maintaining the independence of Ernst & Young as our registered public accounting firm.
Audit Committee Pre-Approval Policy
Rules adopted by the SEC in order to implement requirements of the Sarbanes-Oxley Act of 2002 require audit committees of public companies to pre-approve audit and permissible non-audit services provided by their independent auditors. In the event it becomes necessary to engage the independent auditor for additional services not contemplated in the original pre-approval, the Company will obtain the specific pre-approval of the Audit Committee before engaging the independent auditor. The pre-approval policy requires the Audit Committee to be informed of each service performed by the independent auditor, and the policy does not include any delegation of the Audit Committee’s responsibilities to management. The Audit Committee may delegate pre-approval authority to one or more of its members. The member to whom such authority is delegated will report any pre-approval decisions to the Audit Committee as a whole at its next scheduled meeting. The Audit Committee approved all fees paid to Ernst & Young described in the section above.
Audit Committee Report
In connection with the financial statements for the fiscal year ended March 31, 2008, the Audit Committee has reviewed and discussed the audited financial statements with management, discussed with Ernst & Young the matters required to be discussed by Statement on Auditing Standards No. 61, as amended, as adopted by the Public Company Accounting Oversight Board in Rule 3200T and received a written disclosure and letter from the Auditors for matters required by Independence Standards Board Standard No. 1, and has discussed with Ernst & Young their independence.
Based upon these reviews and discussions, the Audit Committee recommended to the Board that the Company’s audited financial statements be included in the Annual Report on Form 10‑K for the year ended March 31, 2008 filed with the SEC. The Board has approved this inclusion.
AUDIT
COMMITTEE MEMBERS
| Patricia
M. Hollister |
Terrence
W. Glarner |
James D. Hartman |
PROPOSAL 2. RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Our
Audit Committee has selected Ernst & Young LLP as our registered public
accounting firm to audit our financial statements for fiscal 2009 and recommends
that the shareholders ratify the selection. Shareholder ratification is not
required by our Articles of Incorporation but our Board is submitting the selection
for ratification as a matter of good corporate practice. If our shareholders
fail to ratify the selection, our Audit Committee will reconsider whether or
not to retain Ernst & Young. Even if the selection is ratified, our
Audit Committee in its discretion may direct the selection of different independent
auditors at any time during the year if our Audit Committee determines that
such a change would be in our and our shareholders’ best interests. Representatives
of Ernst & Young are expected to be present at our 2008 Annual Meeting
and will have the opportunity to make a statement if they wish to do so. We
also expect that they will be available to respond to appropriate questions.
Ernst & Young has audited our financial statements
annually since our 2001 fiscal year, including our financial statements for
fiscal 2008.
A
copy of our Annual Report to Shareholders for the fiscal year ended March 31,
2008, including financial statements, accompanies this Notice of Annual Meeting
and Proxy Statement. The Annual Report includes our annual report on Form
10‑K as filed with the Securities and Exchange Commission on May 20,
2008. No portion of the Annual Report is incorporated into this proxy statement
or is to be considered proxy-soliciting material. We will provide without
charge to each person receiving a copy of this proxy statement, on the written
request of such person, a copy of our Annual Report on Form 10‑K. Such
written requests should be addressed to Curt A. Reynders, our Secretary, at
the address on the cover page of this Proxy Statement.
| By Order of the Board of Directors | ||
Curt A. Reynders |
||
| Chief Financial Officer and Secretary | ||
June 20, 2008
2008 Annual Meeting
August 7, 2008, 3:30 p.m.
THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE FOLLOWING PROPOSALS:
|
1. |
To elect five directors to serve until the next Annual Meeting of Shareholders. |
||
|
01 Terrence W. Glarner |
04 |
Patricia M. Hollister |
|
|
02 Daniel A. Baker |
05 |
Robert H. Irish |
|
|
03 James D. Hartman |
|||
|
o |
Vote
FOR all nominees |
o |
Vote
WITHHELD |
|
Instructions: To withhold authority to vote for any nominee, strike a line through the name(s). |
|||
|
2. |
To
ratify the selection of Ernst & Young LLP as our independent registered
public accounting firm for the fiscal year ending March 31, 2009. |
||
THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER SPECIFIED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO SPECIFICATION IS MADE, THIS PROXY WILL BE VOTED FOR PROPOSALS 1 AND 2. THE PROXIES ARE AUTHORIZED TO VOTE THIS PROXY IN THEIR DISCRETION WITH RESPECT TO OTHER MATTERS WHICH MAY PROPERLY COME BEFORE THE MEETING.
(please sign on the other side)
THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS. The undersigned, a holder of common stock of NVE Corporation (the “Company”), hereby appoints Curt A. Reynders and Daniel A. Baker, and each of them, the proxy of the undersigned, with full power of substitution, to attend, represent and vote for the undersigned, all of the shares of the Company which the undersigned would be entitled to vote, at the Annual Meeting of Shareholders of the Company to be held on August 7, 2008 and any adjournments thereof.
Date _________________________________
Signature _________________________________
Signature _________________________________
Please sign exactly as name
appears on the label. When shares are held by joint tenants, both should sign.
When signing as attorney, executor, administrator, trustee or guardian, please
give full title as such. If a corporation, please sign in full corporate name
by president or other authorized officer. If a partnership, please sign in partnership
name by authorized person.
PLEASE MARK (ON THE OTHER SIDE), SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY
USING THE ENCLOSED ENVELOPE.